The store will not work correctly when cookies are disabled.
3-Phenyl-5-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102941
PubChem CID: 59699998
Max Phase: Preclinical
Molecular Formula: C21H18N2O2
Molecular Weight: 330.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cc1OC
Standard InChI: InChI=1S/C21H18N2O2/c1-24-19-9-8-15(11-20(19)25-2)16-10-17-18(13-23-21(17)22-12-16)14-6-4-3-5-7-14/h3-13H,1-2H3,(H,22,23)
Standard InChI Key: PTKRZXHHLCHSFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
17.7937 -18.0367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7925 -18.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5074 -19.2769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5056 -17.6240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0792 -17.6244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2209 -18.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2212 -18.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0116 -19.1208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4999 -18.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0111 -17.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3991 -17.0489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2243 -17.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6125 -16.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1763 -15.5957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3476 -15.6262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9631 -16.3537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0824 -16.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3687 -16.3863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6534 -16.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6562 -17.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3705 -18.0367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9383 -16.3877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2245 -16.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9434 -18.0434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2273 -17.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
19 22 1 0
22 23 1 0
20 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.39 | Molecular Weight (Monoisotopic): 330.1368 | AlogP: 4.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 47.14 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.96 | CX LogP: 4.20 | CX LogD: 4.20 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.58 | Np Likeness Score: -0.33 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |
2. Verdonck S, Pu SY, Sorrell FJ, Elkins JM, Froeyen M, Gao LJ, Prugar LI, Dorosky DE, Brannan JM, Barouch-Bentov R, Knapp S, Dye JM, Herdewijn P, Einav S, De Jonghe S.. (2019) Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity., 62 (12): [PMID:31136173] [10.1021/acs.jmedchem.9b00136] |